Related Experiment Video
Updated: Aug 23, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Toll-like receptor 7 regulates cardiovascular diseases
Melika Shafeghat1, Sina Kazemian2, Arya Aminorroaya3
1Research Center for Immunodeficiencies (RCID), Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Chicago, IL, USA.
Toll-like receptor 7 (TLR-7) plays a dual role in cardiovascular disease (CVD) pathogenesis, influencing inflammation, thrombosis, and atherosclerosis. Understanding TLR-7
Area of Science:
- Immunology
- Cardiology
- Molecular Biology
Background:
- Cardiovascular disease (CVD) is a leading global cause of death, with inflammation playing a key role in its development.
- Toll-like receptors (TLRs), particularly TLR-7, are innate immune receptors involved in detecting damage-associated molecular patterns during inflammation and infection.
- TLR-7 is expressed in various cardiovascular cells, including endothelial cells, vascular smooth muscle cells, and platelets, and is activated by single-stranded RNA (ssRNA).
Purpose of the Study:
- To review the current understanding of Toll-like receptor 7 (TLR-7) function in the pathogenesis and development of cardiovascular diseases (CVDs).
- To discuss the dual role of TLR-7 in CVD, encompassing both pro-inflammatory and protective effects.
- To explore emerging therapeutic strategies targeting TLR-7 for CVD treatment.
Main Methods:
- Literature review of recent studies on TLR-7 and its involvement in cardiovascular disease.
- Analysis of TLR-7 signaling pathways and its downstream effects on immune and cardiovascular cells.
- Synthesis of evidence regarding TLR-7's impact on thrombosis, atherosclerosis, and other CVD manifestations.
Main Results:
- TLR-7 activation leads to the release of both pro-inflammatory (IL-1, IL-6, TNF-α) and anti-inflammatory (IL-10) cytokines.
- Activated platelets by TLR-7 can promote thrombus formation and neutrophil aggregation, but also offer protection via GM-CSF release.
- TLR-7 activation is associated with increased risks of complete heart block, myocarditis, left ventricular remodeling, and rupture, while also showing a dual effect on atherosclerotic plaque formation.
Conclusions:
- TLR-7 exhibits a complex, often contradictory, role in cardiovascular disease, influencing multiple pathological processes.
- Further research into TLR-7's intricate mechanisms is crucial for developing targeted therapies.
- Modulating TLR-7 activity presents a potential therapeutic avenue for managing various cardiovascular conditions.
Related Concept Videos
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Regulation of Angiogenesis and Blood Supply
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

